UnitedHealth Group, US91324P1021

UnitedHealth Group consensus in focus, analysts see steady outlook for the shares

Veröffentlicht: 26.06.2026 um 07:42 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

UnitedHealth Group shows a tight consensus picture on Wall Street, with most brokers positive on the Dow Jones health insurer. Ahead of the next earnings report, investors watch growth in premiums and the Optum services arm.

UnitedHealth Group, US91324P1021, Illustration mit AI erstellt.
UnitedHealth Group, US91324P1021, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 07:41.

UnitedHealth Group (US91324P1021) remains one of the largest components in the Dow Jones Industrial Average and a key benchmark for US health-care stocks. The current analyst consensus shows a predominantly positive view on the insurer, based on recent data from several broker surveys. A Reuters earnings report from April 2026 underlined how the group still benefits from solid premium growth and expanding health services activities.

What recent estimates show

According to analyst data compiled by MarketScreener, more than 20 brokers currently cover UnitedHealth Group, with a clear majority rating the stock Buy or Outperform. The average 12-month price target in that overview stands noticeably above the recent New York Stock Exchange price, signaling that many institutions still see upside potential.

The consensus figures follow the first-quarter 2026 earnings release, in which UnitedHealth reported adjusted earnings per share above Wall Street expectations while keeping its full-year outlook unchanged. The official company earnings release from 16 April 2026 showed that revenues increased in both the health benefits business and the Optum health services unit, while management highlighted ongoing investments in technology and care delivery.

Broker views on the Dow component

In recent weeks, several large investment banks have reiterated positive views on UnitedHealth shares, citing the companys scale in US health insurance and its diversified earnings streams. For example, major Wall Street firms such as Goldman Sachs and JPMorgan continue to list the stock with Buy or Overweight ratings in their latest sector reports, pointing to resilient cash flows and a strong balance sheet.

Analysts in these reports emphasize that UnitedHealths position as a leading managed-care company gives it bargaining power with providers and suppliers, which can help stabilize margins even in periods of medical cost volatility. A recent Goldman Sachs sector outlook notes that large diversified players like UnitedHealth and peer Elevance Health can better absorb regulatory changes than smaller insurers.

Go deeper

All news and analysis on the UnitedHealth Group shares

Key figures, news and analysis on UnitedHealth Group are collected on our topic page and in the companys own investor materials.

How UnitedHealth makes its money

UnitedHealth Group generates the majority of its revenue from health insurance premiums in the UnitedHealthcare segment, which serves employers, individuals and public programs such as Medicare and Medicaid in the United States. The company also operates the Optum unit, which bundles pharmacy benefit management, health-care delivery and data analytics services for insurers, employers and health systems.

Where the stock trades today

UnitedHealth Group shares trade on the New York Stock Exchange under the ticker UNH; recent quote services show the stock around 480 US dollars per share on 2026-06-25 in New York trading.

UnitedHealth Group at a glance

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • WKN: 869561
  • Ticker: UNH
  • Trading venue: NYSE
  • Price (as of 2026-06-25, 22:00): 480 USD
  • Market cap: approximately 440 billion USD (as of 2026-06-25)
  • Sector / industry: Health Care - Managed Health Care
  • Index membership: Dow Jones Industrial Average, S&P 500
  • Next earnings date: 2026-07-16

More on the UnitedHealth Group shares in social media

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69629955 | bgmi